Development of a Novel Kidney-focused Approach to Treatment of a Patent Ductus Arteriosus (PDA) in Vulnerable Preterm Neonates - A Pilot Study
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.
Eligibility
Participation Requirements
Sex: All
Minimum Age: Newborn
Maximum Age: 7 days
Healthy Volunteers: f
View:
• Delivered at \<32 weeks' gestation
• ≤72 hours of age
• Inpatient at Meriter Hospital, Inc. NICU
• At least one parent/guardian is able to provide parental permission in English or Spanish
Locations
United States
Wisconsin
Meriter Hospital, Inc.
RECRUITING
Madison
Contact Information
Primary
Paige Condit, MD
pcondit@wisc.edu
616-481-9914
Backup
Meg Baker
meg.baker@wisc.edu
Time Frame
Start Date: 2024-12-19
Estimated Completion Date: 2026-06
Participants
Target number of participants: 45
Treatments
Neonates with PDA
Related Therapeutic Areas
Sponsors
Leads: University of Wisconsin, Madison
Collaborators: The Gerber Foundation